finance.yahoo.com ·
Why Wells Fargo Lowered Amphastar
Topic context
This topic has been covered 383658 times in the last 30 days across our monitored publishers.
The full article is on the original publisher site. This page only shows the headline and a very short excerpt.
AI insight
AI-generatedThe downgrade reflects reduced confidence in Amphastar's revenue growth and competitive positioning, primarily due to uncertainty around AMP-004's interchangeability. The mechanism is a negative sentiment shift affecting the company's stock valuation, but no direct product price or supply chain impact is identified. The commercial mechanism is weak and limited to equity analyst view.
Signals our AI researcher identified
Extracted by our AI model from this article and related public sources — not direct quotes from the publisher.
- Wells Fargo downgraded AMPH to Equal Weight from Overweight on May 13.
- Price objective reduced to $19 from $30.
- Concerns about 2026-2027 revenue trajectory and 2026 outlook.
- Risk related to AMP-004 interchangeability status.
- AMPH is a small cap pharma stock.
Amphastar shares face 2-3% negative sentiment pressure in the next 48 hours due to analyst downgrade.
Sign in to see all sector verdicts, full thesis and counter-argument debate.
Sector impact at a glance
- PHARMA_BIOTECHshort
Related stories
fool.com
Keysight Keys Q2 2026 Earnings Transcript
livemint.com
Haryana Bars Petrol Diesel Cabs for Aggregators What Means Pm Modis Austerity Push Ncrs Aqi Fuel News
proactiveinvestors.com.au
The Morning Catch Up Asx Set to Open Lower Ahead of Pivotal Nvidia Earnings
nbclosangeles.com
Spacex Confirms Plans for IPO
finance.yahoo.com